When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...

Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...

Repurposing and repositioning have gained considerable attention from a range of stakeholders, including NIH, academic institutions, pharmaceutical companies, and even some technology companies, for ...

The last couple of decades has seen increased attention by scientists and medical researchers on drug repurposing and the ...

HERSHEY, Pa. — Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United Stated topped $722 billion, a trend that’s expected to continue. Yet, ...

Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.

As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...